The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•8 May 2026•

1 min read

Clariant Q1 2026 Sales Decline Amid Middle East Geopolitical Tensions

Key Facts

1Q1 2026 sales decreased by 2% in local currencies to CHF 918 million.

2Catalyst volumes were negatively impacted by the Middle East conflict.

3EBITDA margin before exceptional items decreased by 130 basis points to 17.5%.

Clariant reported a 2% decline in Q1 2026 sales in local currencies, totaling CHF 918 million. The company noted that volumes in its Catalysts business were negatively impacted by the ongoing conflict in the Middle East. Additionally, the EBITDA margin before exceptional items contracted by 130 basis points to 17.5%. This margin compression was attributed to geopolitical headwinds and strategic portfolio pruning within the Care Chemicals division. Despite the decline in sales and margins, Clariant highlighted an improvement in cash flow and maintained its full-year guidance. The results underscore the sensitivity of the specialty chemicals sector to regional instability and fluctuating input costs.